The following definitions have been included; however, the list is not exhaustive:

"Change control report” is a document that records the process of coordinated activities through which a desired change is implemented in an existing function, process, or product in the pharmaceutical industry.

“Medical Devices” means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings and animals for one or more specific medical purposes.

“Nuclear Medicine” means a medical specialty that uses radiopharmaceuticals to assess bodily functions and to diagnose and treat disease.

“Radionuclide” is an unstable form of a chemical element that releases radiation as it breaks down and becomes more stable.

“Radiopharmaceutical” means any medicinal product which, when ready for use, contains one or more radionuclides included for medicinal purposes.

“Radiopharmacist” means a pharmacist registered with Council to offer radiopharmaceutical services.

“Specialist pharmacist student” means a pharmacist who is registered as such in terms of the Pharmacy Act 53 of 1974 (the Act).

“Specialist pharmacist resident” means a pharmacist who is registered as such in terms of the Pharmacy Act 53 of 1974 (the Act).

“Specialist Pharmacist” means a pharmacist who is registered as such in terms of the Pharmacy Act 53 of 1974 (the Act).

“Speciality” means a specialist qualification in one of the fields of pharmacy approved and published in rules made by Council.